Milestone Pharmaceuticals Inc.

NASDAQ:MIST

1.47 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 00-0.8680013.51.50015015057.44400000000000
Kosten van de omzet 0.0260.0280.5320.0240.0240.0180.4069.8260.0240.0230.2920.0249.4270.02328.7228.2288.622000000000
Brutowinst -0.026-0.028-1.4-0.024-0.0240.9823.094-8.326-0.024-0.02314.708-0.0245.573-0.02328.722-8.228-8.622000000000
Brutowinstmarge 001.613000.9820.884-5.551000.98100.37200.500000000000
Onderzoek- en ontwikkelingskosten 2.883.7075.4346.7218.62210.25710.5789.82610.6578.76810.9169.7339.4278.5955.7668.2288.62211.87214.1499.54510.5277.7657.2973.9112.5513.091
Algemene en administratieve kosten 5.0463.9533.3714.2274.4453.8894.1234.0343.9183.6433.7872.9613.0182.6331.6742.9522.9562.7032.2792.1041.6410.9791.2180.6460.750.439
Verkoop- en marketingkosten 1.8012.8844.9774.4123.3692.3562.5582.672.2311.6362.2151.5791.8431.3661.3220.9051.5272.1832.4642.0762.1662.1861.5921.2280.3750.725
Verkoop-, algemene en administratieve kosten 6.8216.8097.9088.6397.8146.2456.6816.7046.1495.2796.0024.544.8613.9992.9963.8574.4834.8864.7434.183.8073.1652.811.8741.1251.164
Overige kosten -0.0650000048.9242.672.231045.67401.843000008.8920000000
Bedrijfskosten 9.70110.51613.34215.3616.43616.50217.25916.5316.80614.04716.91814.27314.28812.5948.76212.08513.10516.75818.89213.72514.33410.9310.1075.7853.6764.255
Bedrijfsresultaat -9.727-10.544-13.874-15.36-16.436-15.502-13.759-15.03-16.806-14.047-16.918-14.2730.712-12.594-8.762-12.085-13.105-16.758-18.892-13.725-14.334-10.93-10.107-5.785-3.676-4.255
Bedrijfsresultaat ratio 0015.98400-15.502-3.931-10.0200-1.12800.0470-0.15300000000000
Totaal overige inkomsten en kosten netto 0.2990.1220.1890.2790.3930.5520.5820.4740.1580.04-0.0340.0480.0580.080.0960.0890.1260.4150.6030.8210.6720.50.4460.0850.0890.09
Inkomen voor belasting -9.428-10.422-13.685-15.081-16.043-14.95-13.177-14.556-16.648-14.007-16.884-14.2250.77-12.514-8.666-11.996-12.979-16.343-18.289-12.904-13.662-10.43-9.661-5.7-3.587-4.165
Inkomen voor belasting ratio 0015.76600-14.95-3.765-9.70400-1.12600.0510-0.15100000000000
Belastingkosten -0.065-0.068-0.0741.121.213-0.552-31.435-0.474-0.158-0.040.034-0.2-0.087-0.0910.017-0.01700-0.001-0.073-0.0040.0220.05600.0020.016
Nettowinst -9.363-10.354-13.611-15.081-16.043-14.39818.258-14.082-16.49-13.967-16.884-14.2250.77-12.514-8.666-11.979-12.979-16.343-18.288-12.831-13.658-10.452-9.717-5.7-3.589-4.181
Nettowinstmarge 0015.68100-14.3985.217-9.38800-1.12600.0510-0.15100000000000
WPA (Winst Per Aandeel) -0.14-0.21-0.41-0.35-0.37-0.340.43-0.33-0.39-0.33-0.4-0.340.02-0.3-0.29-0.4-0.53-0.67-0.75-0.52-1.04-0.45-0.41-0.24-0.15-0.18
Verwaterde WPA -0.14-0.21-0.41-0.35-0.37-0.340.43-0.33-0.39-0.33-0.4-0.340.02-0.3-0.29-0.4-0.53-0.67-0.74-0.52-1.04-0.45-0.41-0.24-0.15-0.18
EBITDA -9.701-10.516-13.342-14.216-15.199-15.502-13.759-15.003-16.782-14.024-16.895-14.2490.735-12.571-8.737-12.062-13.08-16.734-18.868-13.716-14.332-10.927-10.105-5.782-3.673-4.253
EBITDA ratio 0015.37100-15.502-3.931-10.00200-1.12600.0490-0.15200000000000